The World’s Longest-Standing, Industry-Leading Touchpoint for the Precision Medicine Ecosystem
The precision medicine field is evolving at lightning speed; from liquid biopsy-driven MRD detection and high‑plex single‑cell and multi‑omic profiling, through to breakthroughs in digital pathology, spatial analytics, and next‑generation IVD assays.
Against this backdrop the 16th World Clinical Biomarkers & Companion Diagnostics Summit returned, delivering its largest and most comprehensive forum to date. Attendees were able to seize the opportunity to uncover the latest translational case studies, global regulatory shifts, and integrated commercialization strategies redefining how biomarkers power drug development, clinical decision‑making, and scalable personalized care.
*This flowchart depicts the forum's end-to-end content, spanning the complete precision medicine co-development lifecycle
Collaborate with 250+ World-Class Organizations
Pharma Giants
Biotech Pioneers